...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Combo with Enzalutamide in Phase 2 Metastatic Prostate Cancer Clinical Trial and with Pfizer’s PARPi, talazoparib, in Phase 1b/2 Triple Negative Breast Cancer Trial

Free
Zenith Epigenetics Photo Gallery


The AGORACOM Photo Gallery is Now Live!

The Photo Gallery can be used to host photos from conferences, charts, maps, headquarters, operations and much more.

To start uploading photos, simply click on the “edit” link at the top right hand side of this box.

Photos can be uploaded by those with a rank of Treasurer and up.